Dana-Farber Brigham Cancer Center
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Dana-Farber Brigham Cancer CenterStem Cell Transplantation and Cellular Therapies Program
450 Brookline Ave.
Boston, Massachusetts, 02215
Boston, Massachusetts, 02215
Website : https://www.dana-farber.org/stem-cell-transplantation-program/
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Number performed | 103 | 153 | 159 | 159 | - |
Program Director
| Name | Phone |
|---|---|
| Cindy Albert | |
| Amy Emmert, MScPH | |
| Julie Porter, MSc | |
| Nancy Tang, MPH, CPA |
Medical Director
| Name | Phone |
|---|---|
| Joseph Antin, MD | |
| Corey Cutler, MD, MPH, FRCPC | |
| Caron Jacobson, MD, MMSc | |
| Sarah Nikiforow, MD, PhD |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Aucatzyl (obecabtagene autoleucel, obe-cel )
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)